Archean chemical industries Limited has announced that its board of directors will convene on February 04, 2026, to review and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting, scheduled to be held in Chennai, will focus on both standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The company has formally notified the National Stock Exchange of India Limited and BSE Limited about the upcoming board meeting in compliance with Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for prevention of Insider Trading, the trading window for designated persons and their immediate relatives will remain closed. This closure, which began following the company's earlier notification dated December 26, 2025, will continue until February 06, 2026.

Regulatory Compliance

Archean Chemical Industries Limited has assured that a copy of the unaudited financial results will be forwarded to the stock exchanges immediately after the board meeting concludes. The company will also publish the financial results as mandated under Regulation 47 of SEBI LODR. Additionally, this intimation has been made available on the company's official website at www.archeanchemicals.com .

The notification was signed by Vijayaraghavan N E, Company Secretary and Compliance Officer, on January 30, 2026, ensuring all regulatory requirements are met ahead of the scheduled board meeting.

Archean Chemical Industries has received disclosure from its promoter Chemikas Speciality LLP regarding the pledge of 9,50,000 equity shares under SEBI regulations. The pledge was created on January 22, 2026, with the formal disclosure made to BSE Limited and National Stock Exchange of India Limited on January 27, 2026.

Pledge Details and Transaction Structure

The pledged shares serve as collateral for loans, with Bajaj Financial Securities Ltd. being the beneficiary entity. This latest pledge represents 0.77% of the company's total share capital and increases the promoter's overall encumbered shareholding.

Promoter Shareholding Analysis

Chemikas Speciality LLP maintains a significant stake in Archean Chemical Industries, with the pledge forming part of its broader shareholding structure. The promoter's total holding and encumbrance details reflect its financial arrangements and commitment to the company.

Regulatory Compliance and Disclosure

The disclosure was made pursuant to Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates promoters to inform stock exchanges about encumbrance of shares. The formal communication was signed by P. Ranjit, Partner of Chemikas Speciality LLP, from Chennai.

The company's shares are listed on both BSE Limited (Scrip Code: 543657) and National Stock Exchange of India Limited (Symbol: ACI). Other promoter entities, including P Ranjit who holds 2,82,65,965 shares (22.90% of total share capital), have not created any encumbrances on their holdings as per the current disclosure.

Impact on Shareholding Structure

With this pledge, Chemikas Speciality LLP's encumbered shareholding has increased from 4.94% to 5.71% of the total share capital. The promoter group continues to maintain substantial ownership in Archean Chemical Industries, with the pledge arrangement facilitating access to financing while retaining ownership rights in the underlying shares.